Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

It is uncertain whether antiphospholipid antibodies (APAs) increase the risk of recurrence after a first unprovoked venous thromboembolism (VTE). We tested for anticardiolipin antibodies, anti–β2 glycoprotein 1 antibodies, and lupus anticoagulant on 2 occasions ∼6 months apart in 307 patients with a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Kearon, Clive, Parpia, Sameer, Spencer, Frederick A., Baglin, Trevor, Stevens, Scott M., Bauer, Kenneth A., Lentz, Steven R., Kessler, Craig M., Douketis, James D., Moll, Stephan, Kaatz, Scott, Schulman, Sam, Connors, Jean M., Ginsberg, Jeffrey S., Spadafora, Luciana, Bhagirath, Vinai, Liaw, Patricia C., Weitz, Jeffrey I., Julian, Jim A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2018
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536697/
https://ncbi.nlm.nih.gov/pubmed/29490924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-09-805689
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares